logo-aisf-512x512
logo-aisf-512x512

AISF VIRTUAL

​MONOTHEMATIC

​CONFERENCE

A.I.S.F.
Associazione Italiana per lo Studio del Fegato
Via Alfredo Catalani, 39 - 00199 ROMA
+39(06)8639.9303 
info@webaisf.org
C.F.: 97088670589
Sede legale: Via Giovanni Nicotera, 24 – 00195 ROMA

A.I.S.F.
Associazione Italiana per lo Studio del Fegato
Via Alfredo Catalani, 39 - 00199 ROMA
+39(06)8639.9303 
info@webaisf.org
C.F.: 97088670589
Sede legale: Via Giovanni Nicotera, 24 – 00195 ROMA


facebook
twitter
linkedin

CONTATTI

info@webaisf.org

+39(06) 8639.9303​

il titolo della Monotematica virtuale AISF

th

Tuesday, October 12

14:00 -14:25​​
State-of-the-Art Translational Lecture​The circadian clock and hepatic metabolism(Sara Montagnese, Padua)
14:25 -16:20
THIRD SESSION: “Update on the new drugs pipeline and results of ongoing new clinical trials on NASH”Coordinators: Elisabetta Bugianesi, Turin - Antonio Gasbarrini, Rome
14:25 -14:45
Lifestyle change strategy and results(Maria Letizia Petroni, Bologna)
14:45-15:05
NAFLD therapeutics: from pathophysiology to new drugs(Elisabetta Bugianesi, Turin)
15:05-15:25
NAFLD and NASH therapy in the diabetic population(Giovanni Targher, Verona)
15:25-15:45
Efficacy and indications of bariatric surgery and endoscopic options(Danila Capoccia, Rome)
15:45 -15:50
Five-minutes summary: How to plan an effective treatment of NAFLD/NASH?(Antonio Gasbarrini, Rome)
15:50 -16:15
Discussion concerning the new drugs pipeline and results of ongoing new clinical trials on NASH
16:15 -19:15
Selected AISF Oral Communications Chair: Mario Masarone, Salerno 
-
OC-01Oleuropein prevents copper-catalyzed dicarbonyl stress in NAFLD miceS.J. Santini, G. Tarantino, A. Alisi, C. Balsano - L’Aquila, Naples RomePresenter: S.J. Santini, L’Aquila
-
OC-02Activation of Liver X Receptor-α in the gut protects against liver injury in nonalcoholic steatohepatitis (NASH)F. Gurrado, G. Lioci, N. Panera, M.R. Braghini, C. De Stefanis, M. Cucco, A. Alisi,G. Svegliati Baroni - Ancona, RomePresenter: F. Gurrado, Ancona
-
OC-03Non-alcoholic fatty liver disease and increased risk of incident primary malignant liver tumours: a meta-analysis of observational cohort studiesA. Dalbeni, S. Conci, T. Valigi, A. Guglielmi, A. Mantovani, D. Sacerdoti - VeronaPresenter: A. Dalbeni, Verona
-
OC-04Epidemiological trends of hepatocellular carcinoma in patients with Metabolic-Dysfunction-Associated Fatty Liver Disease in ItalyM. Cucco, A. Vitale, G. Svegliati-Baroni, G. Marchesini, U. Cillo, F. Trevisani, L. Miele, F. Farinati for the Italian Liver Cancer (ITA.LI.CA) group - Ancona, Bologna, Padua, RomePresenter: M. Cucco, Ancona
-
OC-05The nexus between LncOb rs 10487505 variant, leptin levels and non-alcoholic fatty liver disease in children and adolescentsM. Manco, A. Crudele, A. Mosca, R. Caccamo, R. Braghini, R. De Vito, A. Alterio, R. Sartorelli, F. Pizzolante, F. De Peppo, A. Alisi - RomePresenter: A. Crudele, Rome
-
OC-06A cholestatic pattern predicts liver-related events in patients with nonalcoholic fatty liver diseaseG. Pennisi, R. M. Pipitone, D. Cabibi, M. Enea, M. Romero-Gomez, M. Viganò, E. Bugianesi, V. W. Wong, A. L. Fracanzani, G. Sebastiani, A. Berzigotti, F. Di Salvo, A.G. Giannone, C. La Mantia, G. Lupo, R. Porcasi, F.  Vernuccio, R. Zito, V. Di Marco, C. Cammà, A. Craxì, V. de Ledinghen, S. Grimaudo, S. Petta - Palermo, Seville (Spain), Milan, Turin, Hong Kong, Montreal (Canada), Bern (Switzerland), Pessac (France)Presenter: G. Pennisi, Palermo
-
OC-07A machine learning approach for the classification of NASH vs NAFL in diabetic and non-diabetic subjects reveals a strong association between liver inflammation and adipose tissue dysfunctionS. Sabatini, M. Gaggini, M. Allison, R. Younes, C. Rosso, J.M. Schattenberg, V. Ratziu, E. Bugianesi, Q.M. Anstee, A. Gastaldelli - Pisa, Siena, Cambridge (UK), Turin, Mainz (Germany), Paris (France), Newcastle upon Tyne (UK)Presenter: S. Sabatini, Pisa
-
OC-08Rare ATG 7 genetic variants predispose to severe fatty liver diseaseC. Bianco, F. Malvestiti, G.A. Baselli, O. Jamialahmadi, S. Pelusi, E. Ciociola, P. Dongiovanni, M. Maggioni, F. Tavaglione, A. Cespiati, R.M. Mancina, R. D’Ambrosio, S. Petta, L. Miele, U. Vespasiani Gentilucci, A. Federico, J. Pihlajamaki, E. Bugianesi, A.L. Fracanzani, H. Reeves, G. Soardo, D. Prati, R. Romeo, L.V.C. Valenti - Milan, Gothenburg (Sweden), Palermo, Rome, Naples, Kuopio (Finland), Turin, Newcastle upon Tyne (UK), Udine, Trieste, Catanzaro, Solna (Sweden)Presenter: F. Malvestiti, Milan
-
OC-09Independent determinants of CAP in healthy individuals with dysmetabolismC. Bianco, S. Pelusi, E. Giacopuzzi, L. Santoro, F. Malvestiti, M. Tomasi, I. Marini, R. Carpani, D. Prati, L.V.C. Valenti - MilanPresenter: C. Bianco, Milan
-
OC-10Liver-related and extrahepatic events occurrence in patients with nonalcoholic fatty liver disease: a competing risk analysisG. Pennisi, M. Enea, M. Romero-Gomez, M. Viganò, E. Bugianesi, V. W. Wong, A. L. Fracanzani, G. Sebastiani, J. Boursier, A. Berzigotti, M. Eslam, J. Ampuero, A. Benmassaoud, Y. P. Mendoza, J. George, A. Craxì, C. Camma’, V. de Ledinghen, S. Petta - Palermo, Seville (Spain), Milan, Turin, Hong Kong, Montreal (Canada), Angers (France), Bern (Switzerland), Sydney (Australia), Pessac (France)Presenter: G. Pennisi, Palermo
-
OC-11Development of NAFLD/NASH multidisciplinary board: MetaLiverCat experienceL. Miele, F.R. Ponziani, A. Liguori, A. Nicoletti, F. Fianchi, F. Santopaolo, A. Nesci, F. De Leva, M. G. Marini, B. Aquilanti, G. Matera, S. Della Casa,  A. De Magistris, L. Gagliardi, G. Marrone, M. Biolato, F. Pizzolante, N. De Matthaeis, L. Salvatore,  C. Guidone, M. A. Zocco, D. Pitocco, A.M. De Gaetano, C. De Simone, A. Santoloquido, G. Mingrone, M. Raffaelli, G.A. Miggiano, R. Manfredi, F. M. Vecchio, A. Giaccari, M. Pompili, A. Grieco, A. Gasbarrini - RomePresenter: A. Liguori, Rome
-
OC-12Liver fibrosis progression in a NAFLD cohort with PsoriasisA. Liguori, G. Caldarola, M. Cagnazzo, G. Marrone, M. Biolato, G. Moretta, A. Gasbarrini, C. De Simone, A. Grieco, L. Miele - RomePresenter: A. Liguori, Rome
-
OC-13Free Light Chains as a potential biomarker of inflammation in non-alcoholic steatohepatitisA. Liguori, U. Basile, C. Napodano, G. Marrone, M. Biolato, A. Gasbarrini, G.L. Rapaccini, A. Grieco, L. Miele - RomePresenter: A. Liguori, Rome
-
OC-14Fatty liver Index (FLI) 15 years later: a SANRA (Scale for the quality Assessment of Narrative Review Articles) reappraisalA. Lonardo, S. Ballestri, G. Bedogni, S. Bellentani and C. Tiribelli - Modena, Basovizza (Trieste)Presenter: S. Bellentani, Locarno-Switzerland
Create Website with flazio.com | Free and Easy Website Builder